Riverbridge Partners LLC Repligen Corp Transaction History
Riverbridge Partners LLC
- $7.1 Billion
- Q2 2024
A detailed history of Riverbridge Partners LLC transactions in Repligen Corp stock. As of the latest transaction made, Riverbridge Partners LLC holds 527,872 shares of RGEN stock, worth $77.6 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
527,872
Previous 445,168
18.58%
Holding current value
$77.6 Million
Previous $81.9 Million
18.73%
% of portfolio
0.94%
Previous 1.03%
Shares
7 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.11 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$744 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$677 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$255 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$209 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.15B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....